May 8, 2021 8:40 PM
BACK TO TOP
KSE100
45,174.67
231.06
(0.51%)
ALLSHR
30,475.48
216.19
(0.71%)
KSE30
18,469.87
86.89
(0.47%)
KMI30
73,136.12
290.77
(0.40%)
BKTi
12,355.49
55.32
(0.45%)
OGTi
11,979.24
-62.20
(-0.52%)
KMIALLSHR
21,846.86
21.19
(0.10%)
UPP9
12,963.59
86.38
(0.67%)
NITPGI
9,492.06
39.87
(0.42%)
NBPPGI
11,478.91
64.22
(0.56%)
MZNPI
10,707.38
64.25
(0.60%)
Abbott Laboratories (Pakistan) Limited
PHARMACEUTICALS
Rs.780.20
5.50
(0.71%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Thu, May 6, 2021 12:44 PM
REG
FUT
ODL
Open
774.00
High
782.00
Low
774.00
Volume
26,950
CIRCUIT BREAKER
721.69 — 838.72
DAY RANGE
774.00 — 782.00
52-WEEK RANGE
435.00 — 792.38
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
780.20
VAR
10.00
HAIRCUT
15.00
P/E Ratio (TTM) **
14.93
1-Year Change *
72.31%
YTD Change *
3.29%
Open
766.99
High
770.10
Low
766.99
Close
770.10
Change
-0.59%
LDCP
0.00
Volume
42
Total Trades
5
CIRCUIT BREAKER
702.18 — 858.22
DAY RANGE
766.99 — 770.10
Ask Price
774.99
Ask Volume
5
Bid Price
770.10
Bid Volume
7
Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Abbott Laboratories (Pakistan) Limited is a public limited company incorporated in Pakistan on July 02, 1948. The Company is principally engaged in the manufacture, import and marketing of branded generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital and consumer products.

KEY PEOPLE
Mr. Syed Anis AhmedCEO
Mr. Munir A. ShaikhChairman
Mr. Humayun AltafCompany Secretary
ADDRESS

Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Hyderabad Road, Landhi, Karachi, Pakistan

WEBSITE

www.pk.abbott

REGISTRAR

FAMCO Associates (Pvt) Limited, 8-F, Next to Hotel Faran, Nursery Block 6, P.E.C.H.S, Shahrah-e-Faisal,Karachi

AUDITOR

EY Ford Rhodes, Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
76,381,815.62
Shares
97,900,302
Free Float
21,044,371
Free Float
21.50%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Apr 30, 2021Transmission of Quarterly Report for the Period Ended March 31, 2021 View   PDF
Apr 23, 2021Financial Results for the 1st Quarter Ended March 31, 2021 View   PDF
Mar 31, 2021Transmission of Annual Report for the Year Ended December 31st, 2020 View   PDF
Feb 26, 2021Financial Results for the Year Ended December 31,2020 View   PDF
Oct 29, 2020Transmission of Quarterly Report for the Period Ended September 30, 2020 View   PDF
Oct 28, 2020Financial Result for the Quarter Ended September 30th, 2020 View   PDF
Aug 28, 2020Transmission of Quarterly Report for the Period Ended June 30, 2020 View   PDF
Aug 28, 2020Financial Results for the Quarter Ended June 30th, 2020 View   PDF
Jun 1, 2020Transmission of Quarterly Report period ended View   PDF
Jun 1, 2020Financial Results for the 1st Quarter View   PDF
May 29, 2020Quarterly Report for the period ended March 31st, 2020 View   PDF
May 29, 2020Financial Result for the 1st Quarter View   PDF
DateTitleDocument
Apr 22, 2021Certified Copy of Resolution passed at the 72nd Annual General Meeting View   PDF
Apr 16, 2021Board Meeting View   
Apr 6, 2021Board Meeting Other Than Financial Results View   PDF
Mar 29, 2021Notice of Annual General Meeting View   PDF
Feb 15, 2021Board Meeting View   PDF
Oct 20, 2020Board Meeting View   
Aug 20, 2020Board Meeting View   PDF
May 28, 2020Board Meeting in Progress View   
May 21, 2020Board Meeting View   
May 5, 2020Notice of Annual General Meeting View   PDF
Mar 18, 2020Notice of Annual General Meeting View   PDF
Feb 24, 2020Board Meeting View   
Oct 10, 2019Board Meeting View   
DateTitleDocument
May 4, 2021Credit of Final Cash Dividend View   
May 4, 2021Credit of Final Cash Dividend View   
Mar 8, 2021Unusual Movement in price or volume of M/s Abbott Laboratories (Pakistan) Limited (ABOT) View   
Mar 8, 2021ABOT | Abbott Laboratories (Pakistan) Limited PDF
Dec 18, 2020Information under regulation No. 5.6.1(d) of PSX Rule Book View   PDF
Dec 15, 2020Corporate Briefing Session View   PDF
Sep 18, 2020Dispatch of Interim Cash Dividend View   
Jun 11, 2020Dispatch of Final Dividend Warrants View   
May 29, 2020Re-Appointment of Chief Executive View   PDF
May 29, 2020Re-Appointment of Chairman View   PDF
May 28, 2020Election of Directors View   PDF
May 20, 2020Notice Election of Directors View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2020201920182017
Sales35,283,37730,155,87529,719,27926,088,233
Profit after Taxation4,535,2491,299,8852,694,3334,205,232
EPS46.3313.2827.5242.95
Q1 2021Q3 2020Q2 2020Q1 2020
Sales9,890,7928,438,2418,472,1788,061,493
Profit after Taxation1,442,492985,4441,257,547862,517
EPS14.7310.0712.858.81
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2020201920182017
Gross Profit Margin (%)34.6428.2832.8938.67
Net Profit Margin (%)12.854.319.0716.12
EPS Growth (%)248.87(51.74)(35.93)4.55
PEG0.07(0.66)(0.64)3.57

Payouts

DateFinancial ResultsDetailsBook Closure
February 26, 2021 4:27 PM31/12/2020(YR) 250%(F) (D) 14/04/2021 - 21/04/2021
August 28, 2020 12:14 PM30/06/2020(HYR) 150% (i) (D) 09/09/2020 - 16/09/2020
March 2, 2020 3:11 PM31/12/2019(YR) 75%(F) (D) 20/05/2020 - 27/05/2020
February 21, 2019 3:04 PM31/12/2018(YR) 100%(F) (D) 16/04/2019 - 23/04/2019
August 17, 2018 3:07 PM30/06/2018(HYR) 100% (D) 04/09/2018 - 11/09/2018
February 26, 2018 3:36 PM31/12/2017(YR) 300% (D) 14/04/2018 - 23/04/2018
August 21, 2017 3:09 PM30/06/2017(HYR) 100% (D) 08/09/2017 - 15/09/2017
February 27, 2017 5:03 PM31/12/2016(YR) 300% (D) 11/04/2017 - 18/04/2017
August 19, 2016 3:32 PM30/06/2016(HYR) 100% (D) 06/09/2016 - 16/09/2016
February 19, 2016 4:19 PM31/12/2015(YR) 200% (D) 14/04/2016 - 21/04/2016

Financial Reports